A CRISPR screen for Drosophila DNA viral immunity
NIAID - National Institute of Allergy and Infectious Diseases
About This Grant
Project Summary/Abstract DNA viruses are a difficult problem in health and disease. These viruses, including hepatitis B virus, poxviruses, adenovirus (respiratory diseases), and Epstein-Barr virus cause significant morbidity and mortality in humans. The lab has also used DNA viruses, including baculoviruses and nudiviruses, to naturally control insect pest populations and in biotechnology, for decades. Thus, there is much to be gained in developing a deeper understanding of how hosts and viruses co-evolve and the genetic mechanisms of their interactions. Researchers recently discovered and characterized the first DNA virus found to naturally infect Drosophila. This virus, a nudivirus, is common and causes significant mortality in hosts. The virus was recently adapted to infect D. melanogaster S2 cells, which are an extremely useful tool for studying host genetic factors involved in viral infection. This proposal employs a pooled CRISPR screenof nudivirus infection in S2 cells to identify host proviral factors. This involves transforming a pool of S2 cells with guide RNAs that each target a single gene in the genome and render that gene nonfunctional. Thus, each cell has a different gene knocked out. Cells are then infected with virus, incubated, and sorted based on the intensity of viral infection (measured by anti-capsid antibody in flow cytometry). These pools will then be amplicon sequenced and analyzed for genes that are enriched or depauperate in virus-infected or uninfected pools. Candidate genes will then be followed up by validating the roles for ten of these genes in nudivirus infection using RNAi and overexpression. This is the first such experiment for DNA viruses in Drosophila and promises to identify important pro-nudiviral factors.
Grant Summary
A CRISPR screen for Drosophila DNA viral immunity is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $73K for university, nonprofit, healthcare org. Applications are due 2028-05-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $73K
2028-05-31
- 1Confirm your organization is eligible for A CRISPR screen for Drosophila DNA viral immunity from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
A CRISPR screen for Drosophila DNA viral immunity: Frequently Asked Questions
Who is eligible for the A CRISPR screen for Drosophila DNA viral immunity?
A CRISPR screen for Drosophila DNA viral immunity is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the A CRISPR screen for Drosophila DNA viral immunity provide?
A CRISPR screen for Drosophila DNA viral immunity provides up to $73K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the A CRISPR screen for Drosophila DNA viral immunity deadline?
Applications for A CRISPR screen for Drosophila DNA viral immunity are due 2028-05-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the A CRISPR screen for Drosophila DNA viral immunity?
To apply for A CRISPR screen for Drosophila DNA viral immunity, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.